Medesthetics

JUL-AUG 2019

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link: https://medesthetics.epubxp.com/i/1130917

Contents of this Issue

Navigation

Page 61 of 68

medestheticsmagazine.com | JULY/AUGUST 2019 59 removal decreased by 2.7 percent. Chemical peel and microderm- abrasion fees decreased by 4 percent compared to last year. ASA HONORS THREE FOR SUPPORT OF SKIN HEALTH On April 9, the American Skin Association (ASA) presented awards to three honorees and gathered with supporters, including philanthro- pists, business leaders and many renowned physicians from the fi eld of dermatology to celebrate another successful year of funding research and educating youth on skin health. Allan C. Halpern, MD, of Memorial Sloan Kettering Cancer Center (MSKCC) received ASA's Career Achievement Award for Use of Artifi cial Intelligence in Melanoma Diagnosis and Management. Dr. Halpern is an internationally recognized expert in melanoma and pigmented lesions. He has served as co-chairman of the National Council for Skin Cancer Prevention and is currently chief of the Der- matology Service and co-leader of the Melanoma Disease Manage- ment Team at MSKCC. Ron Menezes, president and general manager of Almirall ac- cepted the Distinguished Corporate Leadership Award on behalf of the company. For more than 75 years, Almirall has been a leading sci- ence and technology company delivering life-transforming medicines while working to discover medical solutions to improve the lives of patients worldwide. Derek Maetzold, founder, president and CEO of Castle Biosciences, received the Technology Innovation in Melanoma Award. Castle Biosciences focuses on the diagnosis and prognosis of underserved cancers. The company was founded with the belief that understanding the genomic-driven biological behavior of a specifi c patient's tumor at the level of the expression of the gene can result in a more objective understanding of the patient's tumor. "We were very proud to honor Dr. Allan Halpern, Almirall and Castle Biosciences for their pioneering efforts in the fi eld of derma- tology, and their outstanding commitment to medical advancement," said Howard P. Milstein, chairman of ASA. "Whether through educa- tion, research or innovation, their critical contributions help further ASA's mission of fi nding cures for melanoma, skin cancer and other skin diseases." WORLDWIDE TRENDS IN AESTHETIC MEDICINE Allergan has released the results of its fi rst worldwide medical aes- thetics study, titled "Allergan 360˚ Aesthetics Report." To develop the report, Allergan reached out to more than 14,500 aesthetically conscious consumers and 1,300 aesthetic physicians in 18 countries, including the United States, Canada, Mexico, Brazil, the United Kingdom, Spain, France, Germany, Italy, Turkey, Russia, Saudi Arabia, India, China, Japan, South Korea, Taiwan and Australia. An advisory board of physicians partnered with the company to interpret the data and compile the fi ndings.

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - JUL-AUG 2019